Janos Feher

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Biochemistry, Medicine and Surgery
Google:
"Janos Feher"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Féher J, Lengyel G. (2012) Silymarin in the prevention and treatment of liver diseases and primary liver cancer. Current Pharmaceutical Biotechnology. 13: 210-7
Negre-Salvayre A, Auge N, Ayala V, et al. (2010) Pathological aspects of lipid peroxidation. Free Radical Research. 44: 1125-71
Fehér J, Lengyel G. (2010) [Hepatocellular carcinoma: occurrence, risk factors, biomarkers]. Orvosi Hetilap. 151: 933-40
Fehér J, Lengyel G. (2008) [Silymarin in the treatment of chronic liver diseases: past and future]. Orvosi Hetilap. 149: 2413-8
Hagymási K, Lengyel G, Nagy E, et al. (2008) Impaired Antioxidant Status in Non-Organ Specific Autoantibody Positive Patients with Non-Alcoholic Fatty Liver Disease Hungarian Medical Journal. 2: 563-570
Eiszrich A, Fehér J. (2007) [Fatty liver in childhood]. Orvosi Hetilap. 148: 2461-8
Nemes B, Sárváry E, Gerlei Z, et al. (2007) [The recurrence of hepatitis C virus after liver transplantation]. Orvosi Hetilap. 148: 1971-9
Lelbach A, Muzes G, Feher J. (2007) Current perspectives of catabolic mediators of cancer cachexia. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 13: RA168-173
Székely E, Tasnádi G, Szentmihályi K, et al. (2007) [Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda]. Orvosi Hetilap. 148: 1095-100
Fraenkel E, Takács R, Hamvas J, et al. (2007) [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. Orvosi Hetilap. 148: 793-8
See more...